Dr. Scott Plotkin, MD
Claim this profileMassachusetts General Hospital
Studies Neurofibromatosis
Studies Acoustic neuroma
6 reported clinical trials
15 drugs studied
Affiliated Hospitals
Clinical Trials Scott Plotkin, MD is currently running
Erenumab + Siltuximab
for Schwannomatosis Pain
This trial is testing two drugs, Siltuximab and Erenumab-Aooe, to see if they can help people with severe pain from schwannomatosis. Siltuximab blocks tumor growth signals, and Erenumab-Aooe blocks pain signals. The trial aims to find out if these drugs can make a difference for people whose pain is hard to treat. Erenumab has been shown to be safe and effective for chronic migraine treatment.
Recruiting0 awards Phase 22 criteria
Educational Letters
for Neurofibromatosis
The goal of this fully decentralized, randomized controlled trial is to compare the efficacy of two educational interventions for individuals with Neurofibromatosis 1 (NF1). The primary objective of the study is to determine which intervention leads to higher rates of evidenced-based health screenings for NF1 patients in primary care settings. Adults with NF1 and parents/guardians of children with NF1 from across the U.S. who do not go to a specialized NF clinic and who have an upcoming annual wellness visits (e.g. an annual physical, a well-child visit, etc.) scheduled with a primary care provider (PCP) are eligible to enroll in the study. To see if you might be eligible, fill out a prescreening survey here: https://redcap.link/mynfguide
Recruiting1 award N/A
More about Scott Plotkin, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Scott Plotkin, MD has experience with
- Brigatinib
- Neratinib
- Erenumab-Aooe
- Siltuximab
- Letters About NF1 Care
- Tanezumab
Breakdown of trials Scott Plotkin, MD has run
Neurofibromatosis
Acoustic neuroma
Chronic Persistent Surgical Pain
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Plotkin, MD specialize in?
Scott Plotkin, MD focuses on Neurofibromatosis and Acoustic neuroma. In particular, much of their work with Neurofibromatosis has involved NF2 positive patients, or patients who are undergoing treatment.
Is Scott Plotkin, MD currently recruiting for clinical trials?
Yes, Scott Plotkin, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Scott Plotkin, MD has studied deeply?
Yes, Scott Plotkin, MD has studied treatments such as Brigatinib, Neratinib, Erenumab-Aooe.
What is the best way to schedule an appointment with Scott Plotkin, MD?
Apply for one of the trials that Scott Plotkin, MD is conducting.
What is the office address of Scott Plotkin, MD?
The office of Scott Plotkin, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.